| Aktie | Ticker | 2026/Q1 | 2025/Q4 | ||||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 52.769.920 $ | +5.722.195 $ | -19,8 % | 109.495.134 $ | +109.495.134 $ | |||
| Evommune, Inc. | EVMN | 29.445.086 $ | +7.518.167 $ | +34,3 % | 21.926.919 $ | +21.926.919 $ | |
| Verastem, Inc. | VSTM | 15.440.000 $ | +15.440.000 $ | ||||
| AmpliTech Group, Inc. | AMPG | 13.234.900 $ | +13.234.900 $ | ||||
| Inventiva S.A. | IVA | 13.064.700 $ | +974.700 $ | +8,1 % | 12.090.000 $ | +12.090.000 $ | |
| PRECIGEN, INC. | PGEN | 12.540.000 $ | +12.540.000 $ | ||||
| Nuvation Bio Inc. | NUVB | 11.200.000 $ | +11.200.000 $ | ||||
| Rani Therapeutics Holdings, Inc. | RANI | 2.694.941 $ | -5.810.059 $ | -68,3 % | 8.505.000 $ | +8.505.000 $ | |
| Aardvark Therapeutics, Inc. | AARD | 6.255.309 $ | +6.255.309 $ | ||||
| Wave Life Sciences Ltd. | WVE | 5.437.500 $ | +5.437.500 $ | ||||
| Clene Inc. | CLNN | 2.125.293 $ | -2.397.513 $ | -53,0 % | 4.522.806 $ | +4.522.806 $ | |
| Generation Bio Co. | GBIO | 3.777.200 $ | +3.777.200 $ | ||||
| CITIGROUP INC | C | 2.400 $ | -600 $ | -20,0 % | 3.000 $ | +3.000 $ | |
| 52.769.920 $ | +5.722.195 $ | -19,8 % | 109.495.134 $ | +109.495.134 $ | |||